These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6773180)

  • 1. Effects of omega-aminoacids and clot formation on the activation by urokinase of various plasminogen preparations.
    Takada A; Takada Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):167-76. PubMed ID: 6773180
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluorescence spectrophotometric studies on the conformational changes induced by omega-aminoacids in two isozymes of Glu-plasminogen (I and II).
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1984 Mar; 33(5):461-9. PubMed ID: 6719394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.
    Takada Y; Takada A
    Thromb Res; 1979; 16(5-6):865-9. PubMed ID: 160629
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorescence polarization and spectropolarimetric studies on the conformational changes induced by omega-aminoacids in two isozymes of Glu-plasminogen (I and II).
    Sugawara Y; Takada Y; Takada A
    Thromb Res; 1984 Feb; 33(3):269-75. PubMed ID: 6710433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator.
    Westlund LE; Lundén R; Wallén P
    Haemostasis; 1982; 11(4):235-41. PubMed ID: 6982199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of Glu-plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):437-43. PubMed ID: 6457415
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of antifibrinolytic agents on wound healing.
    Björlin G; Nilsson IM
    Int J Oral Maxillofac Surg; 1988 Aug; 17(4):275-6. PubMed ID: 3139802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between inhibition of plasminogen-activator activity and prostatic involution.
    Rennie PS; Bowden JF; Bruchovsky N; Cheng H
    Biochem J; 1988 Jun; 252(3):759-64. PubMed ID: 2458715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
    Petersen LC; Brender J; Suenson E
    Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):411-9. PubMed ID: 6459659
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of plasmin with alpha 2-macroglobulin and alpha 2-antiplasmin in the presence and absence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):237-46. PubMed ID: 6157220
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of the activation of Glu-plasminogen by urokinase in the simultaneous presence of tranexamic acid or fibrin.
    Takada A; Sugawara Y; Takada Y
    Haemostasis; 1989; 19(1):26-31. PubMed ID: 2920977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-aminohexanoate and chloride ion in the activation by urokinase of porcine plasminogens.
    Machovich R; Owen WG
    Biochim Biophys Acta; 1990 Aug; 1040(1):109-11. PubMed ID: 2378895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M; Zenker M; Gaffney PJ
    Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation.
    Walther PJ; Hill RL; McKee PA
    J Biol Chem; 1975 Aug; 250(15):5926-33. PubMed ID: 1150667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of the antifibrinolytic action of tranexamic acid.
    Hoylaerts M; Lijnen HR; Collen D
    Biochim Biophys Acta; 1981 Feb; 673(1):75-85. PubMed ID: 7193484
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
    Takada A; Takada Y
    Thromb Res; 1989 Sep; 55(6):717-25. PubMed ID: 2551068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of tranexamic acid on fibrinolysis, fibrinogenolysis and amidolysis.
    Takada A; Makino Y; Takada Y
    Thromb Res; 1986 Apr; 42(1):39-47. PubMed ID: 3705023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.